Search results
Results will auto-populate based on filter selection.
Found 270 result(s)
Provincial health and safety associations are valuable resources for any business. If you’re registered with the WSIB, you automatically receive a free membership to the…
With our Safety Check feature, it’s never been easier to check the safety…
Return-to-work and disability management assessment toolsA business’ disability management program is an important part in the recovery and return to work of employees who…
Businesses covered by our workplace injury and illness insurance pay a rate that reflects their industry and experience.Your premium rate is set using a two-step approachStep…
This section summarizes Part IV of the Workplace Safety and Insurance Act, 1997 as it relates to health professionals.Definition of health…
Find out more about how we make decisions, by reviewing the Operational Policy manual, and adjudication support documents. You’ll also find useful forms and fact…
We’re lowering the average premium rate for Ontario businesses in 2026 to $1.23 per $100 of insurable payroll, the lowest it has been in more than 50 years.The 2026 decrease…
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
On this page:Purpose Fund characteristics and background Regulatory standards…
1. Andrea Furlan, Institute for Work & Health (Toronto)“Extension of Project ECHO Occupational and Environmental Medicine, and testing of a new clinical tool”$299,350…
On this page:Purpose Scope Authority BOD committees External…
Message from Chair and President & CEO On November 14, the Workplace Safety and Insurance Board’s (WSIB) Board of Directors approved the Rate Framework. On behalf of the…
Indication(s)Treatment of schizophrenia.DAC recommendationThe Drug Advisory Committee (DAC) recommended that paliperidone not be listed on any WSIB formularies as there are…
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…
In Q3, the Workplace Safety and Insurance Board (WSIB) continued to build on our successes by improving health and safety outcomes and our financial position. Here are some…
Indication(s)The management of discomfort ± acute muscle spasm associated with painful musculoskeletal (MSK) conditions (cylcobenzaprine, methocarbamol, and orphenadrine).The…
Indication(s)Treatment of schizophrenia and related psychotic disorders, the treatment of acute manic or mixed episodes associated with bipolar disorder.DAC recommendationThe…
AudioVisualN/AWSIB logoI want to thank you for taking some time out of your day to spend an hour talking about return to work and WSIB and how we can help. It does show a…
Paul Demers, Cancer Care Ontario (Toronto) “The Occupational Disease Surveillance System (ODSS): Data to dissemination” $245,532 over two years Dr. Paul Demers, Director,…
On this page: Background Purpose Application and Scope Policy Statement…